Suenson E, Lützen O, Thorsen S
Eur J Biochem. 1984 May 2;140(3):513-22. doi: 10.1111/j.1432-1033.1984.tb08132.x.
This study deals with the effect of fibrin on the transformation of Glu-plasminogen to Glu-plasmin during fibrinolysis. It focuses particularly on changes in fibrin effector function caused by plasmin-catalysed fibrin degradation. Conversion of 125I-labelled Glu-plasminogen to Glu-plasmin was catalysed by urokinase or tissue plasminogen activator, in the presence of different preparations of progressively degraded fibrin. Plasmin catalysis of Glu-plasminogen and the fibrin (derivative) effector was inhibited by aprotinin. The presence of intact fibrin enhanced the rate of Glu-plasmin formation catalysed by tissue plasminogen activator, but not by urokinase. The presence of initially plasmin-cleaved fibrin, however, increased the rates of Glu-plasmin formation with both activators, as compared to those found with intact fibrin. The rate enhancements induced by initial plasmin degradation of the fibrin effector were associated with an increase in its affinity to both Glu-plasminogen and tissue plasminogen activator, suggesting causal relationships. The weak binding of urokinase was unaffected by fibrin degradation, indicating that effector function was solely exerted on the Glu-plasminogen moiety of urokinase-activated systems. Further degradation of fibrin decreased the stimulating effect on Glu-plasmin formation. This decrease occurred at an earlier stage of degradation with tissue plasminogen activator than with urokinase, indicating that greater integrity of the fibrin effector is necessary for its optimal interaction with the tissue plasminogen activator than with Glu-plasminogen. Concentrations of tranexamic acid that saturate low-affinity lysine-binding sites nearly completely dissociated the binding of Glu-plasminogen to degraded fibrin, but not to intact fibrin. In analogy with the binding of lysine analogues to these sites, the conformation of Glu-plasminogen may be altered by binding to degraded fibrin, thus giving rise to the increased activation rate.
本研究探讨了纤维蛋白在纤维蛋白溶解过程中对谷氨酸纤溶酶原转化为谷氨酸纤溶酶的影响。特别关注纤溶酶催化的纤维蛋白降解所引起的纤维蛋白效应功能的变化。在存在不同程度逐步降解的纤维蛋白制剂的情况下,用尿激酶或组织纤溶酶原激活剂催化125I标记的谷氨酸纤溶酶原转化为谷氨酸纤溶酶。抑肽酶可抑制谷氨酸纤溶酶原的纤溶酶催化作用以及纤维蛋白(衍生物)效应。完整纤维蛋白的存在增强了组织纤溶酶原激活剂催化的谷氨酸纤溶酶形成速率,但尿激酶则无此作用。然而,与完整纤维蛋白相比,最初经纤溶酶切割的纤维蛋白的存在增加了两种激活剂作用下的谷氨酸纤溶酶形成速率。纤维蛋白效应物最初经纤溶酶降解所诱导的速率增强与其对谷氨酸纤溶酶原和组织纤溶酶原激活剂的亲和力增加相关,提示存在因果关系。尿激酶的弱结合不受纤维蛋白降解的影响,表明效应功能仅作用于尿激酶激活系统的谷氨酸纤溶酶原部分。纤维蛋白的进一步降解降低了对谷氨酸纤溶酶形成的刺激作用。组织纤溶酶原激活剂作用下这种降低出现在降解的早期阶段,而尿激酶作用下则较晚,这表明纤维蛋白效应物与组织纤溶酶原激活剂的最佳相互作用比与谷氨酸纤溶酶原的相互作用需要更高的完整性。饱和低亲和力赖氨酸结合位点的氨甲环酸浓度几乎完全解离了谷氨酸纤溶酶原与降解纤维蛋白的结合,但未解离与完整纤维蛋白的结合。与赖氨酸类似物与这些位点的结合类似,谷氨酸纤溶酶原与降解纤维蛋白的结合可能会改变其构象,从而导致激活速率增加。